A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

CompletedOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

June 25, 2021

Study Completion Date

June 25, 2021

Conditions
Diabetic Retinopathy
Interventions
DRUG

Finerenone (BAY94-8862)

10 mg or 20 mg Finerenone tablet to be given orally, once daily, administered in the FIDELIO or FIGARO clinical trial.

Trial Locations (62)

0

Centro de Diabetes Cardiovascular IPS Ltda., Barranquilla

110

Taipei Medical University Hospital, Taipei

220

Far Eastern Memorial Hospital, New Taipei City

833

Chang Gung Memorial Hospital Kaohsiung, Kaohsiung City

2730

Steno Diabetes Center Copenhagen, Gentofte Municipality

4300

Holbæk Sygehus, Holbæk

8200

Aarhus Universitetshospital, Skejby, Aarhus N

8800

Viborg Sygehus, Viborg

9000

Aalborg Universitetshospital, Aalborg

10023

ASL TO5, Turin

11217

Taipei Veterans General Hospital, Taipei

11407

Hospital SAS de Jerez de la Frontera, Jerez de la Frontera

24047

ASST Bergamo Ovest, Bergamo

33308

Elixia at Florida Kidney Physicians Southeast, Fort Lauderdale

40705

Taichung Veterans General Hospital, Taichung

60612

John H Stroger Jr. Hospital of Cook County, Chicago

64128

Kansas City VA Medical Center, Kansas City

70006

Crescent City Clinical Research Center, LLC, Metairie

78414

Office of Osvaldo A. Brusco, MD, Corpus Christi

91910

California Institute of Renal Research - Chula Vista, Chula Vista

92243

California Institute of Renal Research, Inc. - El Centro, El Centro

129128

"PHI Central Clinical Hospital RZD-Medicine", Moscow

163001

First City Clinical Hospital n.a. E.E. Volosevich, Arkhangelsk

210011

The Second Affiliated Hospital of Nanjing Medical university, Nanjing

223300

Huai'an First People's Hospital, Nanjing Medical University, Huai'an

394018

Voronezh Regional Clinical Consultancy-Diagnostic Center, Voronezh

394077

City Outpatient Clinic #4, Voronezh

410030

Saratov City Clinical Hospital #9, Saratov

603018

City Clinical Hospital #13 Nizhny Novgorod, Nizhny Novgorod

630091

Novosibirsk State Medical University, Novosibirsk

650066

Kemerovo Regional Clinical Hospital, Kemerovo

660062

Krasnoyarsk Clinical Hospital n.a. N.S. Karpovich, Krasnoyarsk

4428164

Meir Medical Center, Kfar Saba

5822012

Edith Wolfson Medical Center, Holon

6203854

Clalit Health Services, Midgal Hamea, Tel Aviv

02215

Joslin Diabetes Center, Boston

79902-4672

MedResearch, Inc., El Paso

78212-4740

Clinical Advancement Center, PLLC, San Antonio

C1120AAC

Centro Médico Viamonte, CABA

B1824KAJ

Centro de Investigación Médica Lanús, Lanús

B7602CBM

Hospital Privado de la Comunidad, Mar del Plata

C1425AGC

Investigación Clínica Aplicada, Ciudad Autón. de Buenos Aires

D5702AAx

Salud renal, San Luis

DK-7500

Holstebro Hospital, Endocrinology dept., Holstebro

Unknown

Queen Mary Hospital, Hong Kong

Prince of Wales Hospital Hong Kong, Shatin

"Hospital Universitario Virgen de las Nieves, Medicina Interna"

818-8502

Fukuoka University Chikushi Hospital, Chikushino-shi

805-8508

Steel Memorial Yawata Hospital, Kitakyushu

807-0857

Hirohata Naika Clinic, Kitakyushu

078-8234

Medical corporation Yamagata Naika Clinic, Asahikawa

311-0113

Naka Kinen Clinic, Naka

251-0041

Shonan Fujisawa Tokushukai Hospital, Fujisawa

857-1195

Sasebo Chuo Hospital, Sasebo

910-8526

Fukui Prefectural Hospital, Fukui

558-8558

Osaka General Medical Center, Osaka

1250-189

APDP, Lisbon

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

07441

Kangnam Sacred Heart Hospital, Seoul

703 62

Avdelningen för kliniska prövningar AKP, Örebro

751 85

Akademiska Sjukhuset Njurmottagningen, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY